---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-001818"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2024-01-05T23:59:59+00:00"
generated_at: "2026-06-07T03:20:59.921725+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# TriSalus Life Sciences provides slide deck with preliminary 2023 sales, but specific data absent from filing excerpt

## Summary
- Company furnished investor presentation (Exhibit 99.1) covering preliminary 2023 full-year sales and business update.
- Presentation available on company website; no financial figures or guidance changes contained in the truncated exhibit text.
- No other material developments disclosed; uncertainty precludes extraction of concrete numbers.

## SEC filing metadata
- accession: 0001104659-24-001818
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2024-01-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000110465924001818/0001104659-24-001818-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000110465924001818/tm242196d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-001818
- JSON: https://secwatch.observer/filing/0001104659-24-001818.json
- Plain text: https://secwatch.observer/filing/0001104659-24-001818.txt

## Key facts
- Earnings Releases
  TriSalus Life Sciences, Inc. reported preliminary financial results for the year ended December 31, 2023.
  - Period: the year ended December 31, 2023
  - Result: preliminary results
  source text: TriSalus Life Sciences, Inc. (the “Company”) may use a slide presentation, in whole or in part, from time to time in presentation to investors, analysts and others that includes preliminary sales information for the year ended December 31, 2023, as well as a business and product update.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465924001818/0001104659-24-001818-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.